Reliance Foundation donates 250,000 Covid-19 vaccine doses to Kerala govt

Reliance Foundation, the philanthropic arm of Reliance Industries Ltd, on Thursday said it has provided 250,000 free Covid-19 vaccine doses to the Kerala government

Covishield, Covid-19 vaccine
Press Trust of India New Delhi
2 min read Last Updated : Aug 12 2021 | 7:36 PM IST

Reliance Foundation, the philanthropic arm of Reliance Industries Ltd, on Thursday said it has provided 2.5 lakh free COVID-19 vaccine doses to the Kerala government.

"The commitment was formally handed over to the Chief Minister of Kerala, Pinarayi Vijayan, by a delegation from Reliance," it said in a statement.

Vijayan, according to the statement, expressed gratitude and said Reliance Foundation's gesture of solidarity would undoubtedly strengthen the state's vaccination drive.

Reliance Foundation founder-chairperson Nita M Ambani said: "Mass vaccination is the most effective way to protect people from the virus. We rolled out Mission Vaccine Suraksha, for free vaccinations across the country. With these 2.5 lakh free vaccination doses, Reliance Foundation reaffirms its support to the people of Kerala in this hour of need."

The vaccine doses arrived in Kochi on Thursday and were handed over to the Kerala Medical Services Corporation.

Ernakulam District Collector Jaffer Malik received the vaccine doses on behalf of the Kerala government.

The vaccines will be distributed and administered through the Kerala Health Department.

As part of Mission Vaccine Suraksha, over 10 lakh COVID-19 vaccine doses have been administered to employees, family members and dependents across Reliance.

Till date, over 98 per cent of all eligible employees have been covered with at least one dose of COVID-19 vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineKeralaCoronavirus Tests

First Published: Aug 12 2021 | 7:36 PM IST

Next Story